The program, which will provide $100,000 per year for three years, will support epigenetic research in inflammatory bowel disease.
“Epigenetic research could be an important part of approaches to understanding the complex interactions between genetic and environmental factors — for example, diet, bacteria, or medications — affecting the development and course of IBD,” said Caren A. Heller, MD, MBA, CCFA’s Chief Scientific Officer.
Eligible applicants will have completed a PhD within the past seven years, completed a gastroenterology training program and currently hold a position with a North American university. The grant recipient will be selected by an independent panel of AGA and CCFA members.
Applications are due March 15 and the winner will be announced June 15.
More articles on gastroenterology:
GI/endoscopy company stock report – Feb. 13, 2015
GI physician leader to know: Dr. Lin Chang of UCLA
Chromoendoscopy could boost ADR in Lynch syndrome
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.